Gianluca Sbardella

4.7k total citations
107 papers, 3.7k citations indexed

About

Gianluca Sbardella is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Gianluca Sbardella has authored 107 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 30 papers in Organic Chemistry and 19 papers in Infectious Diseases. Recurrent topics in Gianluca Sbardella's work include Epigenetics and DNA Methylation (29 papers), Histone Deacetylase Inhibitors Research (26 papers) and Cancer-related gene regulation (24 papers). Gianluca Sbardella is often cited by papers focused on Epigenetics and DNA Methylation (29 papers), Histone Deacetylase Inhibitors Research (26 papers) and Cancer-related gene regulation (24 papers). Gianluca Sbardella collaborates with scholars based in Italy, United States and Germany. Gianluca Sbardella's co-authors include Antonello Mai, Sabrina Castellano, Marino Artico, Silvio Massa, Mark T. Bedford, Ciro Milite, Monica Viviano, Rino Ragno, Ettore Novellino and Dante Rotili and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Gianluca Sbardella

105 papers receiving 3.6k citations

Peers

Gianluca Sbardella
David L. Selwood United Kingdom
Jeremy S. Caldwell United States
Pavel Majer Czechia
Alfredo G. Tomasselli United States
Aiming Sun United States
Roger Freidinger United States
Subramaniam Ananthan United States
David L. Selwood United Kingdom
Gianluca Sbardella
Citations per year, relative to Gianluca Sbardella Gianluca Sbardella (= 1×) peers David L. Selwood

Countries citing papers authored by Gianluca Sbardella

Since Specialization
Citations

This map shows the geographic impact of Gianluca Sbardella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Sbardella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Sbardella more than expected).

Fields of papers citing papers by Gianluca Sbardella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Sbardella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Sbardella. The network helps show where Gianluca Sbardella may publish in the future.

Co-authorship network of co-authors of Gianluca Sbardella

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Sbardella. A scholar is included among the top collaborators of Gianluca Sbardella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Sbardella. Gianluca Sbardella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiorentino, Francesco, Gianluca Sbardella, Rino Ragno, et al.. (2025). An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 68(6). 5993–6026. 1 indexed citations
2.
Quancard, Jean, Anders Bach, Chiara Borsari, et al.. (2025). The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead. ChemMedChem. 20(8). e202400931–e202400931. 2 indexed citations
3.
Milite, Ciro, Monica Viviano, Alessandra Feoli, et al.. (2024). Prodrug Approach to Exploit (S)‐Alanine Amide as Arginine Mimic Moiety in the Development of Protein Arginine Methyltransferase 4 Inhibitors. ChemMedChem. 19(17). e202400139–e202400139. 2 indexed citations
4.
Viviano, Monica, Alessandra Cipriano, Alessandra Feoli, et al.. (2024). Successes and challenges in the development of BD1-selective BET inhibitors: a patent review. Expert Opinion on Therapeutic Patents. 34(7). 529–545. 2 indexed citations
5.
Feoli, Alessandra, Alessandra Cipriano, Ciro Milite, et al.. (2023). Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor. Journal of Medicinal Chemistry. 66(19). 13665–13683. 9 indexed citations
6.
Quancard, Jean, Anna Vulpetti, Anders Bach, et al.. (2023). The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation. ChemMedChem. 18(9). e202300002–e202300002. 6 indexed citations
7.
Cipriano, Alessandra, Monica Viviano, Alessandra Feoli, et al.. (2023). NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors. Journal of Medicinal Chemistry. 66(17). 11632–11655. 85 indexed citations
8.
Cipriano, Alessandra, Ciro Milite, Alessandra Feoli, et al.. (2022). Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain. ChemMedChem. 17(20). e202200343–e202200343. 9 indexed citations
10.
Scisciola, Lucia, Federica Sarno, Vincenzo Carafa, et al.. (2020). Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence. Epigenetics. 15(6-7). 664–683. 26 indexed citations
11.
Swaminathan, Jyothishmathi, Chandra Das, Shavali Shaik, et al.. (2017). Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation. Molecular Cancer Research. 15(8). 1073–1084. 27 indexed citations
12.
Milite, Ciro, Elisabetta Barresi, Eleonora Da Pozzo, et al.. (2017). Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO). Journal of Medicinal Chemistry. 60(18). 7897–7909. 17 indexed citations
13.
Proto, Maria, Donatella Fiore, Silvia Franceschelli, et al.. (2017). Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer. Scientific Reports. 7(1). 52 indexed citations
14.
Viviano, Monica, Xiaonan Su, Jie Lv, et al.. (2017). Developing Spindlin1 small-molecule inhibitors by using protein microarrays. Nature Chemical Biology. 13(7). 750–756. 46 indexed citations
15.
Milite, Ciro, Alessandra Feoli, Monica Viviano, et al.. (2016). Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors. ChemMedChem. 11(16). 1680–1685. 16 indexed citations
16.
Legartová, Soňa, Gianluca Sbardella, Stanislav Kozubek, & Eva Bártová. (2015). Ellagic Acid-Changed Epigenome of Ribosomal Genes and Condensed RPA194-Positive Regions of Nucleoli in Tumour Cells. Folia Biologica. 61(2). 49–59. 5 indexed citations
17.
Castellano, Sabrina, Cristina Sgherri, Mike Frank Quartacci, et al.. (2013). Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. Journal of Antimicrobial Chemotherapy. 68(5). 1111–1119. 16 indexed citations
18.
Colussi, Claudia, Jessica Rosati, Stefania Straino, et al.. (2011). N ε -lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proceedings of the National Academy of Sciences. 108(7). 2795–2800. 89 indexed citations
19.
Mai, Antonello, Dante Rotili, Prisca Ornaghi, et al.. (2006). Identification of small molecules inhibitors of GCN5 histone acetyltransferase activity. ARKIVOC. 2006(8). 24–37. 4 indexed citations
20.
Roccatano, Danilo, Gianluca Sbardella, Massimiliano Aschi, et al.. (2005). Dynamical Aspects of TEM-1 β-Lactamase Probed by Molecular Dynamics. Journal of Computer-Aided Molecular Design. 19(5). 329–340. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026